Popular on EntSun
- SQHWYD Launches Cognitive Finance Platform with Intelligent Trading Technology and Unified DeFi Access for Brazilian Market - 198
- Phinge CEO Previews a Future Netverse Original Movie Production Model: Offering Viewers Ownership & Rewards in the Future of Original Content & Series - 171
- CRYPTOCURRENCY: Lucrumia Exchange Platform Addresses Italian Traders' Growing Demand for Secure Digital Asset Trading - 164
- Scrambled Eggs Creative Teams Up With Any Means Necessary for First Licensed Collection: The Bag Lady Vinyl Companion - 161
- Swellegant Sinatra Celebration Swings Soon in Avon-By-The-Sea, NJ - 161
- iPOP Alum Elijah Rodriguez to Star in Sicario 3 - 155
- $750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP - 150
- Chaye Alexander of Chayz Lounge Debuts Earn The Return, The Essential Guide for Musicians Ready to Build a Career Beyond Gigs - 147
- Big Packz the Movie - Oct 1st, 2025 on Tubi - 147
- Acclaimed Nature Artist Sara Seelenbrandt Returns with Fall "Wrapped in Nature" Performance at Rhode Island's Spiral Labyrinth - 145
Similar on EntSun
- Bitcoin at $115K: AZETHIO Launches Exchange Targeting Institutional Compliance Requirements
- Dongsheng's Titanium Recycling Business Enters Aerospace Sector by 2025
- Icarus IFE Systems Launches the Icarus One Portable Inflight Entertainment System — The World's Most Advanced Offline AI-Driven IFE Platform
- Phinge Announces Proposal to Combat Billions in Government Waste, Fraud, and Abuse with Proactive, Hardware-Verified Netverse App-Less Platform
- Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
- Poised for Major Growth with Strategic Military Orders, Global Expansion, and Groundbreaking Underground Mining Initiative $RMXI
- Golden Paper Introduces TAD Hand Towel Technology, Ushering in a New Era of Premium Tissue Quality
- Why Generic Platforms Fail in Emerging Markets: Bettorify Exposes the Gap Between Promise and Reality
- Koplon Dentistry Elevates Implant Expertise with Advanced CE Course
- i2 Group Acquisitions and Investments in Innovations Deliver 40% Increase in Year-on-Year Bookings
Encore Technologies Corp Announces Receipt for Final Prospectus and Conditional Approval for Listing
EntSun News/11075422
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States.
VANCOUVER, British Columbia - EntSun -- Encore Technologies Corp. (the "Company") is pleased to announce that it has filed and obtained a receipt for its final long-form prospectus dated October 23, 2025 (the "Prospectus") from the securities regulatory authorities in British Columbia, Alberta and Ontario. The Prospectus qualifies the Company's initial public offering (the "Offering") of 5,000,000 common shares (the "Common Shares") at a price of $0.15 per Common Share, for gross proceeds of $750,000.
The Common Shares are being offered by Leede Financial Inc., acting as agent and sole bookrunner (the "Agent") on a commercially reasonable efforts basis under the terms of an agency agreement dated October 23, 2025 (the "Agency Agreement") between the Company and the Agent. Pursuant to the Agency Agreement, the Company will pay the Agent a cash commission of 7.0% of the gross proceeds of the Offering. The Company will also issue to the Agent non-transferable share purchase warrants equal to 7.0% of the number of Common Shares sold under the Offering, at an exercise price of $0.20 per share for twelve (12) months from the closing date of the Offering. In addition, the Agent will receive a corporate finance fee of $50,000, of which $25,000 has already been paid.
The Company also granted the Agent an over-allotment option to sell up to an additional 750,000 Common Shares (equal to 15% of the Common Shares offered pursuant to the Offering) at $0.15 per Common Share (for additional gross proceeds of up to $112,500), exercisable for 60 calendar days following the closing of the Offering on the same terms as the Offering.
More on EntSun News
The Company has received conditional approval from the Canadian Securities Exchange (the "CSE") for the listing of the Common Shares, subject to the Company satisfying customary conditions, filing all required documentation and closing the Offering. Once final approval is granted, the Common Shares will commence trading under the symbol "ENCR." There can be no guarantee that the CSE will accept the listing of the Company's common shares.
Delivery of the Prospectus (and any amendment thereto) is deemed to have occurred in accordance with the "access equals delivery" provisions of applicable securities legislation. The Company's Prospectus is available for review on SEDAR+ at www.sedarplus.ca under the Company's issuer profile. An electronic or paper copy of the Prospectus, and any amendment, may be obtained without charge from the Agent via email at syndication@leede.ca by providing a valid email or mailing address. The Prospectus contains important and detailed information about the Company and the Offering. Prospective investors are strongly encouraged to read the Prospectus in full before making an investment decision.
About Encore Technologies Corp.
Encore Technologies Corp. builds and invests in technology ventures that advance intelligent infrastructure, energy systems, and data optimization. The Company's platforms leverage data and automation to improve the efficiency, transparency, and sustainability of real-world systems. Encore continues to evaluate opportunities to acquire or develop complementary technologies that align with its vision of a more connected and intelligent built environment.
***
For further information contact:
More on EntSun News
Stephen Kukucha
Chief Executive Officer
Tel: (604) 398-4786
Caution Regarding Forward-Looking Information
This news release contains statements and information that, to the extent they are not historical facts, constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements are based on the beliefs, estimates, and opinions of management as of the date hereof, and reflect management's expectations regarding the Offering, the receipt of listing approval, intended use of proceeds, business strategy, future development, timing of regulatory approvals, client acquisition, platform enhancements, and other matters that are not historical in nature.
Forward-looking information involves significant risks and uncertainties. Key risk factors include, without limitation: the Company's ability to satisfy all conditions required for listing on the CSE; the receipt of final approval from the CSE; completion of the Offering on the terms described or at all; market, economic interest rate conditions; access to and cost of capital; the Company's ability to execute its business plan; the timing, scope and success of client acquisitions and platform development; and other factors described under the "Risk Factors" section of the Prospectus. Actual results may differ materially from those expressed or implied by such forward-looking statements.
Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake any obligation to update or revise forward-looking information contained in this release except as required by applicable securities laws.
The CSE has neither approved nor disapproved the contents of this news release. The CSE does not accept responsibility for the adequacy or accuracy of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The Common Shares are being offered by Leede Financial Inc., acting as agent and sole bookrunner (the "Agent") on a commercially reasonable efforts basis under the terms of an agency agreement dated October 23, 2025 (the "Agency Agreement") between the Company and the Agent. Pursuant to the Agency Agreement, the Company will pay the Agent a cash commission of 7.0% of the gross proceeds of the Offering. The Company will also issue to the Agent non-transferable share purchase warrants equal to 7.0% of the number of Common Shares sold under the Offering, at an exercise price of $0.20 per share for twelve (12) months from the closing date of the Offering. In addition, the Agent will receive a corporate finance fee of $50,000, of which $25,000 has already been paid.
The Company also granted the Agent an over-allotment option to sell up to an additional 750,000 Common Shares (equal to 15% of the Common Shares offered pursuant to the Offering) at $0.15 per Common Share (for additional gross proceeds of up to $112,500), exercisable for 60 calendar days following the closing of the Offering on the same terms as the Offering.
More on EntSun News
- Postmortem Pathology Delivers Expert Private Autopsy Services with Compassion and Precision
- Colorado Families Turn to Private Autopsies for Peace of Mind
- $5.4 Million Growth Acceleration, Fleet Expansion and $1.485 Million Strategic Financing: Multi Ways Holdings (N Y S E: MWG) $MWG
- Delta Capital Group Expands Business Funding Terms Up to 24 Months
- Hip-HopVibe.com Launches HHV Media Network in Partnership with The Publisher Desk
The Company has received conditional approval from the Canadian Securities Exchange (the "CSE") for the listing of the Common Shares, subject to the Company satisfying customary conditions, filing all required documentation and closing the Offering. Once final approval is granted, the Common Shares will commence trading under the symbol "ENCR." There can be no guarantee that the CSE will accept the listing of the Company's common shares.
Delivery of the Prospectus (and any amendment thereto) is deemed to have occurred in accordance with the "access equals delivery" provisions of applicable securities legislation. The Company's Prospectus is available for review on SEDAR+ at www.sedarplus.ca under the Company's issuer profile. An electronic or paper copy of the Prospectus, and any amendment, may be obtained without charge from the Agent via email at syndication@leede.ca by providing a valid email or mailing address. The Prospectus contains important and detailed information about the Company and the Offering. Prospective investors are strongly encouraged to read the Prospectus in full before making an investment decision.
About Encore Technologies Corp.
Encore Technologies Corp. builds and invests in technology ventures that advance intelligent infrastructure, energy systems, and data optimization. The Company's platforms leverage data and automation to improve the efficiency, transparency, and sustainability of real-world systems. Encore continues to evaluate opportunities to acquire or develop complementary technologies that align with its vision of a more connected and intelligent built environment.
***
For further information contact:
More on EntSun News
- CCHR: Misinformation Clouds Debate on Psychiatric Drug Toxicology Transparency
- Hilton Head Realtor becomes Certified Senior Professional
- ELKLOOK's 2025 Halloween Sale is Officially Launched
- Bitcoin at $115K: AZETHIO Launches Exchange Targeting Institutional Compliance Requirements
- Tech gains propel Dow Jones past 47,000 as markets reach record highs amid trade tensions
Stephen Kukucha
Chief Executive Officer
Tel: (604) 398-4786
Caution Regarding Forward-Looking Information
This news release contains statements and information that, to the extent they are not historical facts, constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements are based on the beliefs, estimates, and opinions of management as of the date hereof, and reflect management's expectations regarding the Offering, the receipt of listing approval, intended use of proceeds, business strategy, future development, timing of regulatory approvals, client acquisition, platform enhancements, and other matters that are not historical in nature.
Forward-looking information involves significant risks and uncertainties. Key risk factors include, without limitation: the Company's ability to satisfy all conditions required for listing on the CSE; the receipt of final approval from the CSE; completion of the Offering on the terms described or at all; market, economic interest rate conditions; access to and cost of capital; the Company's ability to execute its business plan; the timing, scope and success of client acquisitions and platform development; and other factors described under the "Risk Factors" section of the Prospectus. Actual results may differ materially from those expressed or implied by such forward-looking statements.
Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake any obligation to update or revise forward-looking information contained in this release except as required by applicable securities laws.
The CSE has neither approved nor disapproved the contents of this news release. The CSE does not accept responsibility for the adequacy or accuracy of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Source: Encore Technologies Corp.
Filed Under: Technology
0 Comments
Latest on EntSun News
- Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
- 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
- Easton & Easton, LLP Sues The Dwelling Place Anaheim and Vineyard USA for Failing to Protect Minor from Church Leaders' Sexual Abuse
- Hypnotic Hijinks of HypnoMarc Rolls into Sunnyvale for One Night Only
- Lokal Media House Earns ServiceTitan Certified Marketer Status
- Wall Street's New Obsession? Tradewinds Aims to Revolutionize the $8B Gentlemen's Club Industry with National Peppermint Hippo™ Strategy $TRWD
- Poised for Major Growth with Strategic Military Orders, Global Expansion, and Groundbreaking Underground Mining Initiative $RMXI
- The Princess of R&B/Blues Is Launching New Music and New Tour!
- Golden Limousine International is a 2025 Ace Award Honoree
- XRP fever is coming again, WOA Crypto helps the new trend and earns tens of thousands of dollars a day
- Helen Welch Stars in "Carpenters: The Songs. The Stories" at New Spire Arts
- Inflation Rebounds Under Tariff Shadow: Wall Street Veteran Kieran Winterbourne Says Macro Signals Matter More Than Market Sentiment
- Mensa Foundation's New Science Program Encourages Hands-On Discovery
- RetroSlang®'s DJ Retro Plushy Looks to Becomes Gen Z's Symbol of Cultural Appreciation
- Golden Paper Introduces TAD Hand Towel Technology, Ushering in a New Era of Premium Tissue Quality
- ReedSmith® Creates Founder-Investor Connections at The Investor Dating Game™ by Tech Coast Venture Network During LA Tech Week
- BayView Entertainment frightens audiences with horror film, "Nahualli" drawn from Mexican folklore
- OfficeSpaces.co Expands Its AI-Powered Website Builder Across North America
- Tobu Railway Group Will Host the Fourth Annual "Take-Akari" Bamboo Lantern Festival in East Tokyo, November 7, 2025 – January 31, 2026
- New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks